NASDAQ: AYTU
Aytu Biopharma Inc Stock Ownership - Who owns Aytu Biopharma?

Insider buying vs selling

Have Aytu Biopharma Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Jarrett DisbrowChief Business Officer2025-06-0916,666$1.50
$25.00kBuy
Joshua R. DisbrowChief Executive Officer2025-06-0966,666$1.50
$100.00kBuy
Joshua R. DisbrowChief Executive Officer2025-02-2815,000$1.30
$19.50kBuy

1 of 1

AYTU insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AYTU insiders and whales buy or sell their stock.

AYTU Shareholders

What type of owners hold Aytu Biopharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Armistice Capital LLC179.55%11,078,956$21.60MInsider
Cerecor Inc157.42%9,713,068$18.94MInsider
James B. Wiegand37.93%2,340,659$4.56MInsider
Ampio Pharmaceuticals Inc19.88%1,226,407$2.39MInsider
Christopher Brooke18.92%1,167,147$2.28MInsider
Nantahala Capital Management LLC17.61%1,086,812$2.12MInsider
Nantahala Capital Management LLC17.61%1,086,812$2.12MInstitution
Carl Dockery14.54%897,425$1.75MInsider
David A. Green8.45%521,250$1.02MInsider
Stonepine Capital Management LLC7.52%463,721$904.26kInstitution

1 of 3

AYTU vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AYTU5.99%94.01%Net BuyingNet Buying
TXMD3.66%96.34%Net BuyingNet Buying
TLPH11.45%88.55%Net BuyingNet Buying
YCBD0.90%99.10%
IMCC3.87%0.00%

Aytu Biopharma Stock Ownership FAQ

Who owns Aytu Biopharma?

Aytu Biopharma (NASDAQ: AYTU) is owned by 30.41% institutional shareholders, 477.27% Aytu Biopharma insiders, and 0.00% retail investors. Armistice Capital LLC is the largest individual Aytu Biopharma shareholder, owning 11.08M shares representing 179.55% of the company. Armistice Capital LLC's Aytu Biopharma shares are currently valued at $21.60M.

If you're new to stock investing, here's how to buy Aytu Biopharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.